静脉曲张与 incidents 静脉血栓栓塞症及外周动脉疾病的关联
该回顾性队列研究利用台湾全民健康保险理赔数据,纳入2001年1月1日至2013年12月31日年龄≥20岁的静脉曲张患者212 984例,并按倾向评分匹配无静脉曲张对照212 984例,排除既往诊断深静脉血栓、肺栓塞或外周动脉疾病者,随访至2014年12月31日。静脉曲张组深静脉血栓发生率6.55/1000人年 vs 对照组1.23/1000人年(绝对风险差5.32,95%CI 5.18-5.46),肺栓塞0.48 vs 0.28/1000人年(绝对风险差0.20,95%CI 0.16-0.24),外周动脉疾病10.73 vs 6.22/1000人年(绝对风险差4.51,95%CI 4.31-4.71)。风险比分别为深静脉血栓5.30(95%CI 5.05-5.56)、肺栓塞1.73(95%CI 1.54-1.94)、外周动脉疾病1.72(95%CI 1.68-1.77)。作者结论认为静脉曲张患者发生深静脉血栓的风险显著升高,但肺栓塞和外周动脉疾病的关联因潜在混杂而较不明确,静脉曲张与深静脉血栓的关联是否为因果或代表共同风险因素尚需进一步研究。
要点
- 静脉曲张患者深静脉血栓发生率为6.55/1000人年,显著高于对照组的1.23/1000人年,绝对风险差5.32(95%CI 5.18-5.46),风险比5.30(95%CI 5.05-5.56)。
- 静脉曲张组肺栓塞发生率为0.48/1000人年 vs 对照组0.28/1000人年,绝对风险差0.20(95%CI 0.16-0.24),风险比1.73(95%CI 1.54-1.94),但作者认为该关联因潜在混杂而较不明确。
- 静脉曲张组外周动脉疾病发生率为10.73/1000人年 vs 对照组6.22/1000人年,绝对风险差4.51(95%CI 4.31-4.71),风险比1.72(95%CI 1.68-1.77),作者同样认为关联因潜在混杂而较不明确。
- 该研究为回顾性队列研究,使用台湾全民健康保险理赔数据,静脉曲张组与对照组各212 984例,中位随访时间深静脉血栓7.5年 vs 7.6年、肺栓塞7.8年 vs 7.7年、外周动脉疾病7.3年 vs 7.4年。
- 作者结论指出静脉曲张与深静脉血栓的关联是否为因果或代表共同风险因素尚需进一步研究。
适用人群与场景
- 年龄20岁及以上、诊断为静脉曲张的患者(静脉曲张组212 984例,平均年龄54.5岁,女性69.3%)。
- 按倾向评分匹配的无静脉曲张对照(212 984例,平均年龄54.3岁,女性70.3%)。
- 排除既往已诊断深静脉血栓、肺栓塞或外周动脉疾病者。
研究设计与关键结果
- 研究类型:回顾性队列研究,使用台湾全民健康保险理赔数据,静脉曲张组与倾向评分匹配对照组各212 984例。
- 主要终点:静脉曲张组深静脉血栓发生率6.55/1000人年(10 360例) vs 对照组1.23/1000人年(1980例),绝对风险差5.32(95%CI 5.18-5.46),风险比5.30(95%CI 5.05-5.56)。
- 肺栓塞发生率:静脉曲张组0.48/1000人年(793例) vs 对照组0.28/1000人年(451例),绝对风险差0.20(95%CI 0.16-0.24),风险比1.73(95%CI 1.54-1.94)。
- 外周动脉疾病发生率:静脉曲张组10.73/1000人年(16 615例) vs 对照组6.22/1000人年(9709例),绝对风险差4.51(95%CI 4.31-4.71),风险比1.72(95%CI 1.68-1.77)。
- 中位随访时间:静脉曲张组深静脉血栓7.5年、肺栓塞7.8年、外周动脉疾病7.3年;对照组深静脉血栓7.6年、肺栓塞7.7年、外周动脉疾病7.4年。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 作者结论:静脉曲张患者发生深静脉血栓的风险显著升高;肺栓塞和外周动脉疾病的关联因潜在混杂而较不明确。
- 局限:作者指出肺栓塞和外周动脉疾病的发现因潜在混杂而较不明确;静脉曲张与深静脉血栓的关联是否为因果或代表共同风险因素尚需进一步研究。
对床旁实践的改变
- 作者认为,在诊断为静脉曲张的成人中,发生深静脉血栓的风险显著升高,临床应对此类患者保持警惕。
- 作者指出,肺栓塞和外周动脉疾病的关联因潜在混杂而较不明确,静脉曲张与深静脉血栓的关联是否为因果或代表共同风险因素尚需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Varicose veins are common but rarely associated with serious health risks. Deep venous thrombosis (DVT), pulmonary embolism (PE), and peripheral artery disease (PAD) are also vascular diseases but associated with serious systemic effects. Little is known about the association between varicose veins and the incidence of other vascular diseases including DVT, PE, and PAD.
OBJECTIVE: To investigate whether varicose veins are associated with an increased risk of DVT, PE, or PAD.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study using claims data from Taiwan's National Health Insurance program. Patients aged 20 years and older with varicose veins were enrolled from January 1, 2001-December 31, 2013, and a control group of patients without varicose veins were matched by propensity score. Patients previously diagnosed with DVT, PE, or PAD were excluded. Follow-up ended December 31, 2014.
EXPOSURES: Presence of varicose veins.
MAIN OUTCOMES AND MEASURES: Incidence rates of DVT, PE, and PAD were assessed in people with and without varicose veins. Cox proportional hazards models were used to estimate relative hazards, with the control group as reference.
RESULTS: There were 212 984 patients in the varicose veins group (mean [SD] age, 54.5 [16.0] years; 69.3% women) and 212 984 in the control group (mean [SD] age, 54.3 [15.6] years; 70.3% women). The median follow-up duration was 7.5 years for DVT, 7.8 years for PE, and 7.3 years for PAD for patients with varicose veins, and for the control group, follow-up duration was 7.6 years for DVT, 7.7 years for PE, and 7.4 years for PAD. The varicose veins group had higher incidence rates than the control group for DVT (6.55 vs 1.23 per 1000 person-years [10 360 vs 1980 cases]; absolute risk difference [ARD], 5.32 [95% CI, 5.18-5.46]), for PE (0.48 for the varicose veins group vs 0.28 for the control group per 1000 person-years [793 vs 451 cases]; ARD, 0.20 [95% CI, 0.16-0.24]), and for PAD (10.73 for the varicose veins group vs 6.22 for the control group per 1000 person-years [16 615 vs 9709 cases]; ARD, 4.51 [95% CI, 4.31-4.71]). The hazard ratios for the varicose veins group compared with the control group were 5.30 (95% CI, 5.05-5.56) for DVT, 1.73 (95% CI, 1.54-1.94) for PE, and 1.72 (95% CI, 1.68-1.77) for PAD.
CONCLUSIONS AND RELEVANCE: Among adults diagnosed with varicose veins, there was a significantly increased risk of incident DVT; the findings for PE and PAD are less clear due to the potential for confounding. Whether the association between varicose veins and DVT is causal or represents a common set of risk factors requires further research.
参考来源
- Chang SL, Huang YL, Lee MC, et al. Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease. JAMA. 2018. PMID: 29486040. doi:10.1001/jama.2018.0246
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。